Gastroesophageal reflux disease: A typical spectrum disease (A new conceptual framework is not needed)

被引:58
作者
Pace, F [1 ]
Porro, GB [1 ]
机构
[1] Univ Milan, L Sacco Hosp Vialba, Dept Gastroenterol, I-20157 Milan, Italy
关键词
D O I
10.1111/j.1572-0241.2004.04164.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux disease (GERD) is a common GI disorder, particularly frequent in the primary care setting, with a high direct and indirect economic burden on society. Despite the high prevalence and costs of the disease, the epidemiology and natural history of GERD have not been fully elucidated. It has recently been suggested to abandon the current model of GERD as a "spectrum" disease and to adopt a new conceptual framework, e.g., categorizing GERD into three unique groups of patients: nonerosive reflux disease, erosive esophagitis, and Barrett's esophagus. In the present review we present arguments against this proposal, and argue that the concept of a single disease, potentially progressing from mild nonerosive forms toward metaplasia and neoplasia (adenocarcinoma), still holds true and may in fact help us in planning the diagnostic and therapeutic approach as well as in allocating financial resources much better than the proposed model of a "tripartited" disease. Independently from the conceptual model adopted, however, more data on the natural history of patients with GERD are eagerly needed.
引用
收藏
页码:946 / 949
页数:4
相关论文
共 31 条
[1]  
[Anonymous], 1974, Dorland's Illustrated Medical Dictionary
[2]  
Baldi F, 1998, ITAL J GASTROENTEROL, V30, P107
[3]   Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole [J].
Carlsson, R ;
Dent, J ;
Watts, R ;
Riley, S ;
Sheikh, R ;
Hatlebakk, J ;
Haug, K ;
de Groot, G ;
van Oudvorst, A ;
Dalvag, A ;
Junghard, O ;
Wiklund, I .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (02) :119-124
[4]   THE RELATION OF GASTROESOPHAGEAL REFLUX DISEASE AND ITS TREATMENT TO ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
CHOW, WH ;
FINKLE, WD ;
MCLAUGHLIN, JK ;
FRANKL, H ;
ZIEL, HK ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (06) :474-477
[5]   Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota [J].
Conio, M ;
Cameron, AJ ;
Romero, Y ;
Branch, CD ;
Schleck, CD ;
Burgart, LJ ;
Zinsmeister, AR ;
Melton, LJ ;
Locke, GR .
GUT, 2001, 48 (03) :304-309
[6]   Endoscopic screening and surveillance for Barrett's esophagus: Can claims data determine its effectiveness? [J].
Cooper, GS .
GASTROINTESTINAL ENDOSCOPY, 2003, 57 (07) :914-916
[7]   LOCATION OF THE LOWER ESOPHAGEAL SPHINCTER AND THE SQUAMOUS COLUMNAR MUCOSAL JUNCTION IN 109 HEALTHY CONTROLS AND 778 PATIENTS WITH DIFFERENT DEGREES OF ENDOSCOPIC ESOPHAGITIS [J].
CSENDES, A ;
MALUENDA, F ;
BRAGHETTO, I ;
CSENDES, P ;
HENRIQUEZ, A ;
QUESADA, MS .
GUT, 1993, 34 (01) :21-27
[8]  
DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434
[9]   The epidemiology of gastroesophageal reflux disease: What we know and what we need to know [J].
Eisen, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08) :S16-S18
[10]   Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer [J].
Farrow, DC ;
Vaughan, TL ;
Sweeney, C ;
Gammon, MD ;
Chow, WH ;
Risch, HA ;
Stanford, JL ;
Hansten, PD ;
Mayne, ST ;
Schoenberg, JB ;
Rotterdam, H ;
Ahsan, H ;
West, AB ;
Dubrow, R ;
Fraumeni, JF ;
Blot, WJ .
CANCER CAUSES & CONTROL, 2000, 11 (03) :231-238